Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Curable is a digital health platform headquartered in Chennai, India. Its core positioning is to connect teleconsultations, early screening, and lab referrals within a single platform. According to its website, it has served 250,000+ patients and works with 2,500+ doctors and 100+ partner hospitals and clinics, primarily targeting the Indian market.
The product is divided into three modules: Telehealth, Screening, and Referral. The teleconsultation module supports video, voice, and chat consultations. Doctors can send digital prescriptions, lab orders, and referrals, and manage follow-ups through appointment booking, rescheduling, and reminders. The site also highlights AI dictation and summarization capabilities. The Screening module is designed for hospitals, rural communities, corporate health camps, and similar scenarios. It supports structured tablet-based data entry, 16-digit patient IDs, automated risk flagging, and instant reports, and can be white-labeled with customizable questionnaires. The Referral module connects doctors, laboratories, and patients, supporting digital lab orders, real-time lab receipt, patient SMS notifications, and result delivery back to the referring party. The website also says medical apps can embed its capabilities via white-label APIs, but it does not provide detailed API documentation or a list of supported third-party systems.
Curable uses custom pricing. Teleconsultations involve a one-time setup and integration fee, plus charges based on completed consultations. Screening can be billed per patient; NGO and government projects have no setup fee, while clinics can also choose a monthly plan. Referrals include lab onboarding and workflow configuration fees, followed by usage-based charges according to referral volume. The advantage is flexibility for organizations of different sizes, but the lack of public pricing ranges means procurement teams need to contact the company by email to estimate budgets.
Curable’s strength is its broad coverage of medical workflows: it can support doctors offering online consultations, hospitals, NGOs, and governments running large-scale screenings, and laboratories seeking digital patient acquisition and result delivery. Doctor feedback suggests the interface is relatively easy to use, and the platform is also described as quick to launch. The main weakness is limited information on security and compliance. The site only states that consultations are encrypted; it does not elaborate on permissions, audit logs, data residency, or compliance certifications. No free trial is disclosed either.
The website does not provide information about access from China, payment methods, or localization, so china_access can only be assessed as unknown. Since its business and medical network are clearly focused on India, Chinese organizations considering Curable should carefully evaluate cross-border compliance, data export requirements, medical licensing, and payment settlement. Domestic alternatives in China include WeDoctor, Haodf.com, Ping An Health, and Alibaba Health, as well as local internet hospitals, HIS/LIS providers, and medical checkup or screening SaaS solutions.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on curable.care official site.
curable.care is an India Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach curable.care directly.